Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable)
Clinical trial NCT04126733 · COMPLETED
Trial details
- NCT number
- NCT04126733
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-14
- Primary completion
- 2020-11-11
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.